Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.Cancer Immunology Research|November 6, 2014
PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutationNemanja Rodić, Robert A Anders, James R Eshleman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway BlockadeJanis M Taube, Geoffrey D Young, Tracee L McMiller, et al.Cancer Immunology Research|January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survivalEvan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.Cell Reports. Medicine|February 22, 2023
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinomaJulie Stein Deutsch, Evan J Lipson, Ludmila Danilova, et al.Cancer Immunology, Immunotherapy : CII|October 30, 2020
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomasFarah Succaria, Pia Kvistborg, Julie E Stein, et al.The Journal of Clinical Investigation|April 15, 2024
T antigen-specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinomaUlla Kring Hansen, Candice D Church, Ana Micaela Carnaz Simões, et al.JAMA Oncology|March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for ImmunotherapyElizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.Pageof 11